Mary Gray, MD


I am Medical Director for Cardiology Clinical Services at San Francisco General Hospital. As inpatient Cardiology Service attending, I am responsible for individuals with acute coronary syndromes, heart failure exacerbations, heart rhythm disorders, endocarditis, and hypertensive emergencies. As inpatient Cardiology Consult attending, I coordinate complex care with Medicine, Family Medicine, Anesthesia, Neurology, Surgery Specialty, and Obstetrics Services. Echocardiography Laboratory and Cardiac Device Clinic duties encompass inpatients and outpatients. Cardiology Clinic and Anticoagulation Clinic duties include urgent evaluation prior to non-cardiac surgery and chronic management of diverse cardiovascular conditions. I respond to electronic requests (eConsults) for cardiology services from hospital areas, San Francisco Health Network clinics, and other healthcare facilities. I coordinate referrals to other UCSF campuses for cardiac electrophysiology, cardiothoracic surgery, and stress imaging procedures. I am Chair of the ZSFG Medication Error Reduction Plan Committee. I am Associate Medical Director for ZSFG Risk Management.
B.A.S., - Biology and English, Stanford University
- Chief Medicine Resident, UC San Diego Dept of Medicine
- Medicine Resident, UC San Diego Dept of Medicine
M.D., - Medical Student, UC San Diego School of Medicine
- Clinical Cardiology Fellow, UC San Francisco
- Postdoctoral Research Fellow, UC San Francisco
  1. Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, Korthuis RJ. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Volume 33 of Issue 2. 2008. PMID: 19032583

  2. Zhang J, Honbo N, Goetzl EJ, Chatterjee K, Karliner JS, Gray MO. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Volume 293 of Issue 5. 2007. PMID: 17766476

  3. Zhou HZ, Ma X, Gray MO, Zhu BQ, Nguyen AP, Baker AJ, Simonis U, Cecchini G, Lovett DH, Karliner JS. Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Volume 358 of Issue 1. 2007. PMID: 17475219

  4. Zhou HZ, Swanson RA, Simonis U, Ma X, Cecchini G, Gray MO. Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Volume 291 of Issue 2. 2006. PMID: 16582021

  5. Jin ZQ, Zhou HZ, Cecchini G, Gray MO, Karliner JS. MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. Volume 288 of Issue 6. 2005. PMID: 15681709

  6. Gray MO, Zhou HZ, Schafhalter-Zoppoth I, Zhu P, Mochly-Rosen D, Messing RO. Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. Volume 279 of Issue 5. 2003. PMID: 14600145

  7. Maklashina E, Sher Y, Zhou HZ, Gray MO, Karliner JS, Cecchini G. Effect of anoxia/reperfusion on the reversible active/de-active transition of NADH-ubiquinone oxidoreductase (complex I) in rat heart. Volume 1556 of Issue 1. 2002. PMID: 12351213

  8. Zhou HZ, Karliner JS, Gray MO. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Volume 283 of Issue 1. 2002. PMID: 12063287

  9. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS, Gray MO. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Volume 282 of Issue 6. 2002. PMID: 12003800